IOL CHEMICALS & PHARM. | GENNEX LAB. | IOL CHEMICALS & PHARM./ GENNEX LAB. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 36.0 | 38.0% | View Chart |
P/BV | x | 1.6 | 4.6 | 33.5% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. GENNEX LAB. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
GENNEX LAB. Mar-23 |
IOL CHEMICALS & PHARM./ GENNEX LAB. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 9 | 5,897.8% | |
Low | Rs | 272 | 5 | 5,659.0% | |
Sales per share (Unadj.) | Rs | 377.6 | 3.4 | 11,239.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.3 | 8,507.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.3 | 9,546.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 4.5 | 5,645.6% | |
Shares outstanding (eoy) | m | 58.71 | 176.64 | 33.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.1 | 51.7% | |
Avg P/E ratio | x | 17.1 | 25.0 | 68.3% | |
P/CF ratio (eoy) | x | 12.8 | 21.0 | 60.9% | |
Price / Book Value ratio | x | 1.6 | 1.5 | 103.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,229 | 1,932.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 79 | 2,136.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 593 | 3,735.7% | |
Other income | Rs m | 256 | 40 | 647.9% | |
Total revenues | Rs m | 22,427 | 633 | 3,542.8% | |
Gross profit | Rs m | 2,257 | 47 | 4,808.7% | |
Depreciation | Rs m | 462 | 9 | 5,022.9% | |
Interest | Rs m | 165 | 14 | 1,216.4% | |
Profit before tax | Rs m | 1,887 | 64 | 2,960.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 15 | 3,409.8% | |
Profit after tax | Rs m | 1,391 | 49 | 2,827.5% | |
Gross profit margin | % | 10.2 | 7.9 | 128.7% | |
Effective tax rate | % | 26.2 | 22.8 | 115.2% | |
Net profit margin | % | 6.3 | 8.3 | 75.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 487 | 1,985.6% | |
Current liabilities | Rs m | 5,025 | 295 | 1,702.7% | |
Net working cap to sales | % | 20.9 | 32.3 | 64.8% | |
Current ratio | x | 1.9 | 1.6 | 116.6% | |
Inventory Days | Days | 43 | 4 | 1,070.3% | |
Debtors Days | Days | 8 | 57,912,589 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 835 | 1,319.5% | |
Share capital | Rs m | 587 | 180 | 325.8% | |
"Free" reserves | Rs m | 14,490 | 623 | 2,324.7% | |
Net worth | Rs m | 15,077 | 804 | 1,876.4% | |
Long term debt | Rs m | 0 | 163 | 0.0% | |
Total assets | Rs m | 20,684 | 1,322 | 1,564.8% | |
Interest coverage | x | 12.5 | 5.7 | 218.2% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 238.7% | |
Return on assets | % | 7.5 | 4.7 | 158.5% | |
Return on equity | % | 9.2 | 6.1 | 150.7% | |
Return on capital | % | 13.6 | 8.0 | 170.2% | |
Exports to sales | % | 26.7 | 42.1 | 63.5% | |
Imports to sales | % | 0 | 13.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 250 | 2,370.8% | |
Imports (cif) | Rs m | NA | 81 | 0.0% | |
Fx inflow | Rs m | 5,930 | 250 | 2,370.8% | |
Fx outflow | Rs m | 6,052 | 86 | 7,011.7% | |
Net fx | Rs m | -122 | 164 | -74.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 237 | 516.4% | |
From Investments | Rs m | -1,200 | -383 | 313.1% | |
From Financial Activity | Rs m | -41 | 210 | -19.5% | |
Net Cashflow | Rs m | -18 | 64 | -28.8% |
Indian Promoters | % | 48.2 | 18.4 | 261.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 81.6 | 63.5% | |
Shareholders | 130,003 | 83,996 | 154.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | GENNEX LABORATORIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -1.99% | 0.97% |
1-Month | 5.64% | 0.62% | 2.08% |
1-Year | -1.14% | 178.42% | 55.37% |
3-Year CAGR | -12.91% | 30.78% | 15.04% |
5-Year CAGR | 16.34% | 47.39% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the GENNEX LABORATORIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of GENNEX LABORATORIES the stake stands at 18.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of GENNEX LABORATORIES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
GENNEX LABORATORIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of GENNEX LABORATORIES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.